Hours
How to get here
Upon arrival
When departing

Quotes and payment methods
ACUNSA Insurance
Other insurance companies

Obtain a remote medical opinion for your clinical case, from your home and without travelling, with the quality and support of the Clínica Universidad de Navarra.

Request a Second Opinion

If you want us to contact you, tell us your phone number and we will call you.

I accept the Terms and conditions, and the Data protection policy

Please indicate when you would prefer that we call you:

Any time Morning (9:00 - 12:00) * Midday (12:00 - 16:00) * Afternoon (16:00 - 21:00) *

* Operating hours based on Spanish (Peninsula) time.

Thank you. We will be in touch shortly.

The Phone no. field is required.

Please review the phone no. indicated, which must contain 9-15 digits and begin with 6,8,9,71,72,73 or 74. For international numbers please indicate 00, followed by the international country code, followed by the phone number.

You must accept Terms and conditions, and the Data protection policy.

Wait a few moments while we process your request.

Close Submit

Av. Pío XII, 36
31008. Pamplona (Navarra), España Contact us

patient area

Headquarters in Madrid

make an appointment

DISEASES
AND TREATMENTS
- We are an international leader in highly specialized procedures.
CHECK-UPS
AND HEALTH
- - MEDICAL CHECK-UPS
  - SPORTS CHECK
  Prevention constitutes the best way to enjoy a longer and healthier life.
ABOUT
US
- Our objective is to offer the patient the best possible medical and human treatment.
OUR
PROFESSIONALS
- - MEDICAL SERVICES
  - DOCTORS & MEDICAL STAFF
  Speed and effectiveness in admission, diagnosis and access to treatment.
RESEARCH&TRIALS
- - CLINICAL TRIALS
  - SCIENTIFIC PUBLICATIONS
  We are the private Spanish medical facility conducting the most clinical trials.
INTERNATIONAL
PATIENTS

Estudio para investigar la eficacia y seguridad de ligelizumab (QGE031) en el tratamiento de la urticaria crónica espontánea (UCE) en adolescentes y adultos inadecuadamente controlados

Dr. Marta Ferrer Puga - Allergology and Immunology Department

El propósito de este estudio es evaluar la eficacia y seguridad de ligelizumab durante el tratamiento de pacientes adultos y adolescentes con urticaria crónica espontánea

Technical Summary

Estudio multicéntrico, aleatorizado, doble ciego, con control activo y placebo para investigar la eficacia y seguridad de ligelizumab (QGE031) en el tratamiento de la urticaria crónica espontánea (UCE) en adolescentes y adultos inadecuadamente controlados con antihistamínicos H1
Code EudraCT: 2018-000840-24
Protocol number: CQGE031C2303
Promoter: Novartis Farmaceutica
LINK TO CLINICAL TRIALS

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

¿QUIERE ENVIARNOS SUS INFORMES?

Si lo prefiere, puede enviarnos su información médica y nuestros especialistas valorarán su caso sin necesidad de venir a la Clínica.

tal vezLE INTERESE

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra